Ana Hećimović Selected Research

Ana Hećimović Research Topics

6	COVID-19 12/2023 - 09/2021
1	Infections 12/2023
1	Hemoptysis 03/2023
1	Tuberculosis (Tuberculoses) 03/2023
1	Lung Injury 01/2023
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Transfusion Reaction 01/2022
1	Venous Thromboembolism 11/2021
1	Pulmonary Embolism 11/2021
1	Weight Gain 09/2021
1	Disease Progression 06/2021
1	Clinical Deterioration 06/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2021
1	Measles 01/2021
1	Mumps 01/2021
1	Pulmonary Hypertension 03/2019
1	Respiratory Insufficiency (Respiratory Failure) 12/2017
1	Anemia 12/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2017
1	Hypoalbuminemia 12/2017
1	Hypertension (High Blood Pressure) 01/2015
1	Lymphomatoid Granulomatosis (Granulomatosis, Lymphomatoid) 03/2010

2	AntibodiesIBA 12/2023 - 01/2022
2	VaccinesIBA 12/2023 - 01/2022
2	Neutralizing AntibodiesIBA 12/2023 - 01/2021
2	Blood Group Antigens (Blood Groups)IBA 11/2022 - 11/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 01/2021
1	2019-nCoV Vaccine mRNA-1273IBA 12/2023
1	BNT162 VaccineIBA 12/2023
1	Ad26COVS1IBA 12/2023
1	Proteins (Proteins, Gene)FDA Link 12/2023
1	nintedanibIBA 01/2023
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023
1	Immunoglobulin M (IgM)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	ABO Blood-Group SystemIBA 11/2021
1	Antiviral Agents (Antivirals)IBA 06/2021
1	Biomarkers (Surrogate Marker)IBA 04/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	CamphorIBA 03/2019
1	TroponinIBA 12/2017
1	Carbon MonoxideIBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2010
1	SteroidsIBA 03/2010

5	Therapeutics 03/2023 - 03/2010
1	Blood Transfusion (Blood Transfusions) 06/2022
1	Lung Transplantation 09/2021
1	Artificial Respiration (Mechanical Ventilation) 12/2017